We are live on ! Find out more
MMSI icon

Merit Medical Systems

86.36 USD
-0.11
0.13%
At close Updated Sep 11, 4:00 PM EDT
1 day
-0.13%
5 days
-1.51%
1 month
-5.21%
3 months
29.11%
6 months
23.23%
Year to date
-0.1%
1 year
-4.27%
5 years
20.6%
10 years
252.49%
 

About: Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Employees: 7,500

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 55.2%
Neutral 41.4%
Negative 3.4%
Neutral
GlobeNewsWire
8 days ago
Merit Medical to Participate in Upcoming Investors Conferences in September
SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences:
Merit Medical to Participate in Upcoming Investors Conferences in September
Neutral
Zacks Investment Research
9 days ago
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Neutral
Zacks Investment Research
15 days ago
Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves
Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.
Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves
Positive
Zacks Investment Research
18 days ago
Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?
Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broaden its mix, but its premium valuation raises the execution bar.
Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?
Positive
Zacks Investment Research
18 days ago
Can MMSI Sustain Its 22.2% Gain in the Past Month as Growth Improves?
Merit Medical's 22.2% monthly rally gains support from stronger Q2 growth and a raised 2026 outlook, but valuation and tariff risks remain.
Can MMSI Sustain Its 22.2% Gain in the Past Month as Growth Improves?
Positive
Zacks Investment Research
21 days ago
COO vs. MMSI: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
COO vs. MMSI: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
23 days ago
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
Neutral
GlobeNewsWire
23 days ago
Merit Medical Announces Global Operations Leadership Transition
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as Executive Vice President of Global Operations, effective August 31, 2026.
Merit Medical Announces Global Operations Leadership Transition
Neutral
MarketBeat
28 days ago
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage
Merit Medical Systems NASDAQ: MMSI is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event.
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage
Positive
MarketBeat
28 days ago
Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum
Merit Medical Systems NASDAQ: MMSI is preparing its next long-range plan as the medical-device company works through a leadership transition, updates its reporting structure and seeks to build on recent revenue and margin momentum.
Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum
Price charts implemented using Lightweight Charts™